Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility Study of BMAC in CHF Patients Undergoing CABG
NCT01074099Phase 2Terminated
- Sponsor
- Terumo
- Start
- Feb 2011
- Primary completion
- Apr 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow nucleated cells in heart failure (HF), sponsored by Terumo. Started Feb 2011; status: terminated.
02
Drugs
autologous bone marrow nucleated cells
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01074099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01074099.